Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of KLRS will decline by -25.99% over the next 2 Weeks and hit $4.31 by Tuesday, April 28, 2026. In that time frame, KLRS's share price is expected to range between $3.33 and $5.18.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Apr 28, 2026 | 3.33 | 4.31 | 5.18 |
| Apr 27, 2026 | 3.51 | 4.46 | 5.45 |
| Apr 24, 2026 | 3.54 | 4.44 | 5.38 |
| Apr 23, 2026 | 3.87 | 4.79 | 5.67 |
| Apr 22, 2026 | 3.95 | 4.89 | 5.85 |
| Apr 21, 2026 | 4.19 | 5.15 | 6.10 |
| Apr 20, 2026 | 4.36 | 5.30 | 6.25 |
| Apr 17, 2026 | 4.44 | 5.28 | 6.30 |
| Apr 16, 2026 | 4.75 | 5.63 | 6.56 |
| Apr 15, 2026 | 4.82 | 5.73 | 6.69 |
KLRS shares rose +8.52% in Thursday, April 16, 2026's trading session, rising from a previous close of $5.87 to move at $6.37. The stock demonstrated notable intraday movement (see KLRS's key stats for a full breakdown), fluctuating between $6.00 and $6.43, a +7.17% trading range. While recent weeks have seen some volatility, KLRS has managed to secure a +10.40% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 140.25K shares changing hands, 100.74K more than the previous session. This amounted to $893.39K in total market activity.
Will KLRS Continue Its Downward Trend?
According to analyst ratings and projections for KLRS, Kalaris Therapeutics Inc shares are anticipated to decrease by -23.03%, potentially reaching $5.18 per share by April 28, 2026. Short-term technical indicators for KLRS currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 21 negative trading days within the past 30 sessions. Based on the KLRS stock forecast, now is not the best time to buy KLRS stock because its current trading price is +47.89% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on KLRS covering social and institutional perspectives.
KLRS Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into KLRS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 42.94% to 49.47%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 46.56%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 48.09%, maintains a neutral outlook for the long term. Insights into KLRS's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Kalaris Therapeutics Short-Term Forecasts
KLRS Forecast For Next 5 Days
Our algorithm anticipates Kalaris Therapeutics (KLRS) stock could hit $4.40 by Apr 23, 2026. This represents a -30.99% rise from today's price, following a +10.97% change over the past five days.
KLRS Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Kalaris Therapeutics Inc (KLRS) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $4.04, which would mean a -36.58% decrease from the current price of $6.37. Projections for this period range from a high of $6.40 to a low of $1.83.
KLRS Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Kalaris Therapeutics's price over the next three months point to a rise. KLRS stock is expected to peak at $24.08 on Jun 15, 2026 before potentially dipping to $3.09 on Jul 06, 2026. On average, KLRS is likely to trade around $13.62 in the coming 90 days.
Kalaris Therapeutics Stock Forecast 2025
Based on our predictive models, Kalaris Therapeutics (KLRS) is expected to trade between $0.00 and $44.94 throughout 2026. This would result in an average price of $16.89, potentially offering investors a +165.15% return from current levels.
Kalaris Therapeutics Inc Monthly Forecast 2026–2027
April 2026
According to our latest forecast models, Kalaris Therapeutics Inc (KLRS) is positioned to show a strong performance in April 2026. The price is predicted to move between $15.02 and $19.27, settling at an average of $17.42. This could translate to a +173.47% gain.
May 2026
Based on current market signals, Kalaris Therapeutics Inc is projected to trend may 2026. We forecast a trading range from $9.00 to $14.88, with a likely average price of $11.59. Investors could expect a potential return of +81.95%.
June 2026
Our predictive algorithms indicate Kalaris Therapeutics Inc stock may see a shift in June 2026. The expected range spans $7.16–$24.08, with an average target of $17.97. This represents a positive outlook and a possible gain of +182.10%.
July 2026
Analyzing established trends, Kalaris Therapeutics Inc looks set to move in July 2026. Projections place the stock between $3.09 and $19.26, averaging around $11.09. This suggests a +74.10% gain from current levels.
August 2026
Market indicators suggest Kalaris Therapeutics Inc could experience notable changes during August 2026. Prices could fluctuate within $0.00 to $10.36, with a midpoint forecast of $1.71. The stock might deliver a -73.16% loss.
September 2026
Forecasting for September 2026, models estimate that Kalaris Therapeutics Inc may undergo key fluctuations. If trends hold, the stock might trade between $3.89 and $18.49, averaging $11.11. This signals a positive trajectory with potential returns around +74.41%.
October 2026
According to our latest forecast models, Kalaris Therapeutics Inc (KLRS) is positioned to show a strong performance in October 2026. The price is predicted to move between $16.07 and $23.38, settling at an average of $19.49. This could translate to a +205.97% gain.
November 2026
Based on current market signals, Kalaris Therapeutics Inc is projected to trend november 2026. We forecast a trading range from $17.35 to $36.71, with a likely average price of $29.36. Investors could expect a potential return of +360.91%.
December 2026
Our predictive algorithms indicate Kalaris Therapeutics Inc stock may see a shift in December 2026. The expected range spans $16.85–$44.94, with an average target of $31.76. This represents a positive outlook and a possible gain of +398.59%.
January 2027
Analyzing established trends, Kalaris Therapeutics Inc looks set to move in January 2027. Projections place the stock between $12.35 and $31.79, averaging around $18.50. This suggests a +190.42% gain from current levels.
February 2027
Market indicators suggest Kalaris Therapeutics Inc could experience notable changes during February 2027. Prices could fluctuate within $22.52 to $32.55, with a midpoint forecast of $26.70. The stock might deliver a +319.15% gain.
March 2027
Forecasting for March 2027, models estimate that Kalaris Therapeutics Inc may undergo key fluctuations. If trends hold, the stock might trade between $20.67 and $37.02, averaging $28.77. This signals a positive trajectory with potential returns around +351.65%.
April 2027
According to our latest forecast models, Kalaris Therapeutics Inc (KLRS) is positioned to show a strong performance in April 2027. The price is predicted to move between $27.71 and $40.34, settling at an average of $36.17. This could translate to a +467.82% gain.
KLRS's history of dividends and stock splits also plays a role in long-term investor confidence.